시너지이노베이션

048870KOSDAQ의료용 기기 제조업

58.5 / 100

Reference Date: 2026-07-24

Financial Score29.0 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers and PER is significantly undervalued vs. peers is also solid. Declined 7.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Synergy Innovation primarily manufactures and sells microbial culture media, produced in ISO13485 and KGMP-certified clean environments. In 2025, the company achieved total sales of 11.31 trillion KRW, with the medical sector contributing the largest share at 66.6%, followed by biotechnology (18.8%) and health functional food (12.4%). It operates through seven affiliated companies across biotechnology, medical devices, and health food sectors.

Number of Employees

65people

Average Salary

49.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

12.15Industry Average 20.046.5Point

Lower than industry avg (good)

PBR

0.50Industry Average 1.147.0Point

Half of industry avg (excellent)

ROE

4.39Industry Average 8.002.5Point

Below industry avg

Debt Ratio

6.02Industry Average 11.655.0Point

Lower than industry avg (good)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲16.8% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲13.2% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 5.4% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 2Negative 0Average Sentiment Score 50

Neutral
바이브컴퍼니, 롯데멤버스·제로투원파트너스와 'AI 페르소나 가상 조.....
AI 기술 협력 협약 발표로 바이브컴퍼니의 기술적 확장 기대되나, 시너지이노베이션(048870)에 직접적 영향은 제한적.
Neutral
美 4월 주택가격지수 0.1% 하락…"모기지 금리 부담"
미국 주택가격지수 하락은 글로벌 경제에 영향을 미칠 수 있으나, 시너지이노베이션의 직접적인 영향은 제한적이다.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 1,542Won52-week high 3,06552-week low 1,501

1-month return1.0Point

1m -7.50% (falling)

Volume trend5.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral[기재정정]주요사항보고서(타법인주식및출자증권양도결정)2026-06-30